Patents by Inventor Eugene O. Major

Eugene O. Major has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of neuro-derived fetal cell lines for transplantation therapy
    Publication number: 20020110546
    Abstract: Human fetal neuro-derived cell lines are implanted into host tissues. The methods allow for treatment of a variety of neurological disorders and other diseases. A preferred cell line is SVG.
    Type: Application
    Filed: October 10, 2001
    Publication date: August 15, 2002
    Applicant: Pro-Virus, Inc.
    Inventors: Eugene O. Major, Carlo S. Tornatore, Kris Bankiewicz
  • Use of neuro-glial cell lines for transplantation therapy
    Patent number: 5869463
    Abstract: Human fetal neuro-derived cell lines are implanted into host tissues. The methods allow for treatment of a variety of neurological disorders and other diseases. A preferred cell line is SVG.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: February 9, 1999
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Eugene O. Major, Carlo S. Tornatore
  • Use of neuro-derived fetal cell lines for transplantation therapy
    Patent number: 5753491
    Abstract: The present invention generally relates to methods for treating a host by implanting genetically unrelated cells in the host. More particularly, the present invention provides human fetal neuro-derived cell lines, and methods of treating a host by implantation of these immortalized human fetal neuro-derived cells into the host.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: May 19, 1998
    Inventors: Eugene O. Major, Carlo S. Tornatore, Gal Yadid
  • Use of neuro-glial fetal cell lines for transplantation therapy
    Patent number: 5690927
    Abstract: Human fetal neuro-derived cell lines are implanted into host tissues. The methods allow for treatment of a variety of neurological disorders and other diseases. A preferred cell line is SVG.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: November 25, 1997
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Eugene O. Major, Carlo S. Tornatore, Kris Bankiewicz
  • Immortal line of human fetal glial cells
    Patent number: 4707448
    Abstract: The present invention discloses permanent establishment of an immortal line of fetal glial cells. The fetal glial cell line is capable of mitotically proliferating and continually growing in vitro under suitable culture media and environmental conditions. A method of producing immortalized human fetal glial cell line is also disclosed. The method comprises transfecting primary human fetal glial cells with an origin-defective mutant of SV40 virus, passaging the resulting astroglial cells through suitable number of cycles and obtaining the desired cell line. The cell line of the present invention is capable of supporting multiplication of JC virus.
    Type: Grant
    Filed: October 4, 1984
    Date of Patent: November 17, 1987
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventor: Eugene O. Major